Payment overview · 2025
General Payments
$174.00
3 reported records · 2 companies
Healthcare provider profile · identity verified
Mark W Bates, M.D.
Allopathic & Osteopathic Physicians|Family Medicine|Geriatric Medicine · BYRON CENTER, MI · NPI 1245312917
Verified facts
What the public records show
CMS Open Payments records show Mark W Bates, M.D. received $174.00 in general payments during 2025 across 3 reported records.
Medtronic, Inc. accounted for 87.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$152.00 | 87.4% | 2 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $22.00 | 12.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $174.00 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| COREVALVE EVOLUT R Normalized: corevalve evolut r |
Device | Medtronic, Inc. | $152.00 | 2 | 2025 |
Source payment records
|
|||||
| General - Catheters Normalized: general catheters |
Device | Boston Scientific Corporation | $22.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 317 | 94 |
| Levothyroxine Sodium | Levothyroxine Sodium | 267 | 80 |
| Lisinopril | Lisinopril | 177 | 46 |
| Pantoprazole Sodium | Pantoprazole Sodium | 164 | 48 |
| Amlodipine Besylate | Amlodipine Besylate | 161 | 47 |
| Omeprazole | Omeprazole | 159 | 45 |
| Eliquis | Apixaban | 120 | 42 |
| Metoprolol Succinate | Metoprolol Succinate | 114 | 35 |
| Tamsulosin Hcl | Tamsulosin Hcl | 103 | 30 |
| Sertraline Hcl | Sertraline Hcl | 99 | 33 |
| Furosemide | Furosemide | 96 | 38 |
| Gabapentin | Gabapentin | 95 | 42 |
| Losartan Potassium | Losartan Potassium | 88 | 24 |
| Trazodone Hcl | Trazodone Hcl | 88 | 29 |
| Donepezil Hcl | Donepezil Hcl | 83 | 14 |
| Carvedilol | Carvedilol | 76 | 27 |
| Mirtazapine | Mirtazapine | 76 | 19 |
| Famotidine | Famotidine | 72 | 22 |
| Metformin Hcl | Metformin Hcl | 70 | 26 |
| Escitalopram Oxalate | Escitalopram Oxalate | 69 | 20 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 63 | 19 |
| Metoprolol Tartrate | Metoprolol Tartrate | 62 | 17 |
| Xarelto | Rivaroxaban | 61 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 59 | 24 |
| Buspirone Hcl | Buspirone Hcl | 58 | 16 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 57 | 36 |
| Potassium Chloride | Potassium Chloride | 55 | 25 |
| Quetiapine Fumarate | Quetiapine Fumarate | 54 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 53 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 52 | 17 |
| Hydrochlorothiazide | Hydrochlorothiazide | 51 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 51 | 14 |
| Alendronate Sodium | Alendronate Sodium | 46 | suppressed |
| Simvastatin | Simvastatin | 46 | 12 |
| Pravastatin Sodium | Pravastatin Sodium | 45 | 13 |
| Methocarbamol | Methocarbamol | 44 | 17 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 44 | 13 |
| Jardiance | Empagliflozin | 43 | suppressed |
| Baclofen | Baclofen | 41 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 40 | suppressed |
| Levetiracetam | Levetiracetam | 37 | suppressed |
| Allopurinol | Allopurinol | 36 | 15 |
| Finasteride | Finasteride | 34 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 34 | 13 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 34 | 12 |
| Tramadol Hcl | Tramadol Hcl | 33 | 17 |
| Nystatin | Nystatin | 32 | 18 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 31 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 30 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 30 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 29 | suppressed |
| Bupropion Xl | Bupropion Hcl | 28 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 27 | 15 |
| Torsemide | Torsemide | 27 | suppressed |
| Cephalexin | Cephalexin | 26 | 24 |
| Clopidogrel | Clopidogrel Bisulfate | 24 | suppressed |
| Memantine Hcl | Memantine Hcl | 24 | suppressed |
| Lorazepam | Lorazepam | 23 | suppressed |
| Spironolactone | Spironolactone | 23 | suppressed |
| Myrbetriq | Mirabegron | 22 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 21 | suppressed |
| Galantamine Er | Galantamine Hbr | 21 | suppressed |
| Lamotrigine | Lamotrigine | 21 | suppressed |
| Loperamide | Loperamide Hcl | 21 | suppressed |
| Nitroglycerin | Nitroglycerin | 21 | 19 |
| Montelukast Sodium | Montelukast Sodium | 20 | suppressed |
| Nabumetone | Nabumetone | 20 | suppressed |
| Benzonatate | Benzonatate | 19 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 19 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 19 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 19 | suppressed |
| Entresto | Sacubitril/Valsartan | 18 | suppressed |
| Folic Acid | Folic Acid | 18 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 18 | 16 |
| Nystop | Nystatin | 18 | 12 |
| Ondansetron Odt | Ondansetron | 18 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 18 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 18 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 17 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 17 | suppressed |
| Meloxicam | Meloxicam | 17 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Linzess | Linaclotide | 16 | suppressed |
| Mounjaro | Tirzepatide | 16 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | 12 |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 16 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 15 | suppressed |
| Nyamyc | Nystatin | 15 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 14 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 14 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 13 | suppressed |
| Clotrimazole | Clotrimazole | 13 | suppressed |
| Dutasteride | Dutasteride | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 12 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Levetiracetam Er | Levetiracetam | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Prednisone | Prednisone | 12 | suppressed |
| Probenecid | Probenecid | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 12 | suppressed |
| Creon | Lipase/Protease/Amylase | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Naproxen | Naproxen | 11 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 11 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $174.00 · 3 records | Medtronic, Inc. | COREVALVE EVOLUT R, General - Catheters | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error